It has been recently revealed that there has been the development of a new stem cell by the scientists. These stem cells are grown in the lab and are taken from the human embryos. They are apparently of the best quality so far and can help in further research, towards the end of the next year, and would also be able to be used in clinical trials in the time to come.
It has been revealed that the stem cell trials conducted in the past have used research grading of lower quality. These were actually manipulated to make it the ‘clinical grade’. This time however the grade of stem cells used is the best one and they are of the clinical quality and come right from the patients for trials. This is the reason they can do without conversions. These stem cells are also untouched by the animal bi -products that are usually used for the stimulation of growth by other research teams.
“The key here is that these are clinical grade lines, they have been set up from the beginning as lines that do not contain animal products and have not got animal products coming into contact with them”, revealed Professor Peter Braude, one of the leading authors of the team.
It was further revealed that though such researches may have been done in the past by private drug firms, this is the first time it has been conducted on such a large scale, for the aid of public health.
This research might surely benefit the field of regenerative medicine in many ways. It might surely help scientists in developing newer way of cure and treatment for patients in the future.